This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Akmaev IG. Neuroimmunoendocrinology: sources and prospects of development. Succ Physiol Sci. 2003;34/4:4–15.AkmaevIGNeuroimmunoendocrinology: sources and prospects of developmentSucc Physiol Sci2003344415Search in Google Scholar
Ashmarin IP, Koroleva SV. Regularities of interaction and functional continuum of neuropeptides (on the way to a unified concept): Overview. Bull Rus Acad Med Sci..2002;6:40–48.AshmarinIPKorolevaSVRegularities of interaction and functional continuum of neuropeptides (on the way to a unified concept): OverviewBull Rus Acad Med Sci200264048Search in Google Scholar
Ashmarin I.P., Nezavibatko V.N., Myasoedov N.F., Kamensky A.A., Grivennikov I.A., Ponomareva-Stepnaya M.A. et al. Nootropic analogue of adrenocorticotropin 4-10-semax (the experience of design and investigation over 15 years). Journal of Higher Nervous Activity. I. Pavlova. 1997; 47(2): 429–430.AshmarinI.P.NezavibatkoV.N.MyasoedovN.F.KamenskyA.A.GrivennikovI.A.Ponomareva-StepnayaM.A.Nootropic analogue of adrenocorticotropin 4-10-semax (the experience of design and investigation over 15 years)Journal of Higher Nervous Activity. I. Pavlova1997472429430Search in Google Scholar
Ashmarin IP, Obukhova MF. The current state of the hypothesis of a functional continuum of regulatory peptides. Vestnik RAMN. 1994;10:28–34.AshmarinIPObukhovaMFThe current state of the hypothesis of a functional continuum of regulatory peptidesVestnik RAMN1994102834Search in Google Scholar
Belokrylov GA, Malchanova IV. Levamin and cerebrolysin as immunostimulants. Biull Eksp Biol Med. 1992;113(2):165–6.BelokrylovGAMalchanovaIVLevamin and cerebrolysin as immunostimulantsBiull Eksp Biol Med19921132165610.1007/BF00791503Search in Google Scholar
Bulgakova OS. Immunity and various stages of stress effects. Succ Mod Nat Sci. 2011;4:31–35.BulgakovaOSImmunity and various stages of stress effectsSucc Mod Nat Sci201143135Search in Google Scholar
Dolotov OV, Eremin KO, Andreeva LA et al. Semax prevents the death of tyrosine hydroxylase-positive neurons in a mixed neuroglial cell culture derived from the embryonic rat mesencephalon in a model of 6-hydroxydopamine-induced neurotoxicity.. Neurochemistry. 2015;32/4:317–321.DolotovOVEreminKOAndreevaLASemax prevents the death of tyrosine hydroxylase-positive neurons in a mixed neuroglial cell culture derived from the embryonic rat mesencephalon in a model of 6-hydroxydopamine-induced neurotoxicityNeurochemistry201532431732110.1134/S1819712415040066Search in Google Scholar
Eremin K.O., Kudrin V.S., Rayevsky K.S., Saransaari P., Oja S.S., Grivennikov I.A., Myasoedov N.F. Semax, an ACTH(4–10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neurochemical Research. 2005; 30(12): 1493–1500.EreminK.O.KudrinV.S.RayevskyK.S.SaransaariP.OjaS.S.GrivennikovI.A.MyasoedovN.FSemax, an ACTH(4–10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodentsNeurochemical Research200530121493150010.1007/s11064-005-8826-816362768Search in Google Scholar
Gabbyasova Yu.R., Tret’yakov D.A., Pleten’ A.P. Peptides of the brain (review). New science: current state and development paths. 2017; 3/3:36–41.GabbyasovaYu.R.Tret’yakovD.A.Pleten’A.P.Peptides of the brain (review)New science: current state and development paths2017333641Search in Google Scholar
Garmanchuk LV, Perepelitsyna EM, Sidorenko Mv, Makarenko AN, Kul’chikov AE. Cytoprotective effect of neuropeptides on immunocompetent cells (in vitro study). Eksperimental clinical pharmakology. 2009; Jul–Aug;72(4):28–32.GarmanchukLVPerepelitsynaEMSidorenkoMvMakarenkoANKul’chikovAECytoprotective effect of neuropeptides on immunocompetent cells (in vitro study)Eksperimental clinical pharmakology2009Jul–Aug7242832Search in Google Scholar
Gromov L.A. Neuropeptides. Kiev: Zdorov’e; 1992; 245.GromovL.A.NeuropeptidesKievZdorov’e1992245Search in Google Scholar
Kolomin T.A., Agapova T. Yu., Agnilullin Ya. V., Shram S.I., Shadrina M.I., Slominskiy P.A. i dr. Change in the transcriptome profile of the hippocampus in response to the introduction of the analog of taftcin selank. Journal of Higher Nervous Activity. I. Pavlova.2013; 63(3): 365–374.KolominT.A.AgapovaT. Yu.AgnilullinYa. V.ShramS.I.ShadrinaM.I.SlominskiyP.A. i dr.Change in the transcriptome profile of the hippocampus in response to the introduction of the analog of taftcin selankJournal of Higher Nervous Activity. I. Pavlova2013633365374Search in Google Scholar
Kudryavtseva NN. Serotonergic control of aggressive behavior: new approaches - new interpretations (review). J High Nerv Act.(I.P. Pavlova). 2015:65/5:546.KudryavtsevaNNSerotonergic control of aggressive behavior: new approaches - new interpretations (review)J High Nerv Act.(I.P. Pavlova)2015655546Search in Google Scholar
Levitskaya N.G., Glazova N.Yu., Sebentsova E.A., Manchenko D.M., Vilenskiy D.A., Andreeva L.A. Investigation of the spectrum of physiological activity of analogue ACTG4-10 heptapeptide semax. Neurochemistry. 2008; 25(1): 111–118.LevitskayaN.G.GlazovaN.Yu.SebentsovaE.A.ManchenkoD.M.VilenskiyD.A.AndreevaL.AInvestigation of the spectrum of physiological activity of analogue ACTG4-10 heptapeptide semaxNeurochemistry2008251111118Search in Google Scholar
Mironov AN, ed. A guide to preclinical drug research. Part One. Moscow, Grief and K; 2012: 944MironovANed.A guide to preclinical drug research. Part OneMoscowGrief and K2012944Search in Google Scholar
Perel’muter V.M., Odintsov Yu. N., Kliment’eva T.K. Taftsin is a natural immunomodulator. Possible role in tumor progression. Siberian Journal of Oncology. 2004; 12(4): C. 57–62.Perel’muterV.M.OdintsovYu. N.Kliment’evaT.K.Taftsin is a natural immunomodulator. Possible role in tumor progressionSiberian Journal of Oncology2004124C.5762Search in Google Scholar
Titov VN. Biological function of stress, congenital immunity, inflammation reaction and arterial hypertension. Clin Lab Diagn. 2008;12:3–16.TitovVNBiological function of stress, congenital immunity, inflammation reaction and arterial hypertensionClin Lab Diagn200812316Search in Google Scholar
Fedorova OV, Krayushkina NG, Shefer EG. Poststressing modulation of immunogenesis organs. Bull Volg State Med Univ. 2010;3/35:8–12.FedorovaOVKrayushkinaNGSheferEGPoststressing modulation of immunogenesis organsBull Volg State Med Univ2010335812Search in Google Scholar
Khavinson VKh, Kvetnoy IM, Ashmarin IP. Peptidergic regulation of homeostasis. Succ Mod Biol. 2002;122:190–203.KhavinsonVKhKvetnoyIMAshmarinIPPeptidergic regulation of homeostasisSucc Mod Biol2002122190203Search in Google Scholar
Khnychenko LK, Sapronov NS. Stress and its role in the development of pathological processes. Rev Clin Pharm Drug Ther. 2003; 2/3:2–15.KhnychenkoLKSapronovNSStress and its role in the development of pathological processesRev Clin Pharm Drug Ther200323215Search in Google Scholar
Sever’yanova L.A., Bobyntsev I.I., Kryukov A.A. Neuropeptides and active amino acids: effects on various types of pain sensitivity and pain-induced behavior. Patogenez. 2005; 3(1): 23–24.Sever’yanovaL.A.BobyntsevI.I.KryukovA.A.Neuropeptides and active amino acids: effects on various types of pain sensitivity and pain-induced behaviorPatogenez2005312324Search in Google Scholar
Skrebitskiy VG, Kasyan AP, Povarov IS, Kondratenko RV, Slominskiy PA. Neuropeptide drug Selank: biological activity and fundamental mechanisms of action. Nerv Dis. 2016; 4:52–56.SkrebitskiyVGKasyanAPPovarovISKondratenkoRVSlominskiyPANeuropeptide drug Selank: biological activity and fundamental mechanisms of actionNerv Dis201645256Search in Google Scholar
Uchakina O.N., Uchakin P.N., Myasoedov N.F., Andreeva L.A., Shcherbenko V.E., Mezentseva M.V. Immunomodulating properties of Selank in people with anxiety-asthenic disorders. Journal of Neurology and Psychiatry. S.S. Korsakov.2008; 5: 71–75.UchakinaO.N.UchakinP.N.MyasoedovN.F.AndreevaL.A.ShcherbenkoV.E.MezentsevaM.V.Immunomodulating properties of Selank in people with anxiety-asthenic disordersJournal of Neurology and Psychiatry. S.S. Korsakov200857175Search in Google Scholar
Volkova A., Shadrina M., Kolomin T., Andreeva L., Limborska S., Myasoedov N., Slominsky P. Selank administration affects the expression of some genes involved in gabaergic neurotransmission. Frontiers in Pharmacology. 2016; 7: 31.VolkovaA.ShadrinaM.KolominT.AndreevaL.LimborskaS.MyasoedovN.SlominskyP.Selank administration affects the expression of some genes involved in gabaergic neurotransmissionFrontiers in Pharmacology201673110.3389/fphar.2016.00031475766926924987Search in Google Scholar
Deak T, Quinn M, Cidlowski JA, Victoria NC, Murphy AZ, Sheridan JF. Neuroimmune mechanisms of stress: sex differences, developmental plasticity, and implications for stress-related disease. Stress 2015;18(4):367–380.DeakTQuinnMCidlowskiJAVictoriaNCMurphyAZSheridanJFNeuroimmune mechanisms of stress: sex differences, developmental plasticity, and implications for stress-related diseaseStress201518436738010.3109/10253890.2015.1053451481331026176590Search in Google Scholar
Formichi P, Radi E, Battisti C, Di Maio G, Muresanu D, Federico A. Cerebrolysin administration reduces oxidative stress-induced apoptosis in lymphocytes from healthy individuals. J Cell Mol Med. 2012;16(11):2840–2843.FormichiPRadiEBattistiCDi MaioGMuresanuDFedericoACerebrolysin administration reduces oxidative stress-induced apoptosis in lymphocytes from healthy individualsJ Cell Mol Med201216112840284310.1111/j.1582-4934.2012.01615.x411825222882711Search in Google Scholar
Hallberg M. Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors. Med Res Rev. 2015;35(3):464–519HallbergMNeuropeptides: metabolism to bioactive fragments and the pharmacology of their receptorsMed Res Rev201535346451910.1002/med.2132324894913Search in Google Scholar
Semmens DC, Elphick MR. The evolution of neuropeptide signalling: insights from echinoderms. Brief Funct Genomics. 2017;16(5):288–298.SemmensDCElphickMRThe evolution of neuropeptide signalling: insights from echinodermsBrief Funct Genomics201716528829810.1093/bfgp/elx005586047128444138Search in Google Scholar
Yugan YL, Sotskaya YA, Chabarova AB. The effectiveness of the modern immunoactive preparation immunofan for medical rehabilitation of patients with nonalcoholic steatohepatitisis against neurocirculatory dystonia, after infectious mononucleosis. Lik Sprava. 2015; (5–6):132–139.YuganYLSotskayaYAChabarovaABThe effectiveness of the modern immunoactive preparation immunofan for medical rehabilitation of patients with nonalcoholic steatohepatitisis against neurocirculatory dystonia, after infectious mononucleosisLik Sprava20155–6132139Search in Google Scholar